Knowledge Bank

Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’

Regeneron has won US Food and Drug Administration (FDA) approval for Pasatru (garetosmab-grts) in a rare connective tissue disorder, placing…